ILARIS

novartis pharmaceuticals canada inc🇨🇦 Health Canada

Approval Id: 7eea2d2df7005108
Drug Approval Canada Name: ILARIS
Product Name: ILARIS
Status: Marketed
Status Date: 2017-08-22
Original Market Date: 2017-08-22
Din: 02460351
Drug Class: Human
Dosage Form: Solution
Route Of Administration: Subcutaneous
Schedule: Prescription , Schedule D
Ahfs: 90:28.00
Atc Original: L04AC08 CANAKINUMAB
Atc Name: l 04 ac 08
Aig Number: 0152696001
Company Name: novartis pharmaceuticals canada inc
Company Address: 100, 700 Rue Saint-Hubert, Montreal, Quebec, Canada, H2Y 0C1

CANAKINUMAB

150 MG / ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

7eea2d2df7005108

Type

Standard